Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related…
$1.94-6.73%
报价 2026-11-13
市值
$18.7M
EV
$13.7M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -89.4%
$0.80$18.27
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| EDSAEdesa Biotech, Inc. | $18.7M | -6.7% | – | 0% | – | – | – | |
| IGCIGC Pharma, Inc. | $20.5M | -4.6% | +25.0% | 21.9% | – | – | – | |
| FLNAFilana Therapeutics, Inc. | $20.5M | -5.1% | – | 0% | – | – | – | |
| CELUCelularity Inc. | $20.4M | -8.0% | +76.0% | 19.2% | – | – | – | |
| ENLVEnlivex Therapeutics Ltd. | $20M | -4.4% | – | 0% | 0.0x | – | – | |
| ATOSAtossa Therapeutics, Inc. | $19.6M | +1.0% | +765.1% | 0% | – | – | – | |
| COCPCocrystal Pharma, Inc. | $18.9M | -1.0% | -100.0% | 0% | – | – | – | |
| KTTAPasithea Therapeutics Corp. | $17.4M | +0.4% | -100.0% | 0% | – | – | – | |
| EVAXEvaxion Biotech A/S | $17.3M | -1.1% | – | 100% | – | – | – | |
| 同行中位数 | – | – | +25.0% | 0% | 0.0x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。